Text Size

Positron Emission Tomography (PET)-Computed Tomography (CT) in Inflammatory Bowel Disease (IBD)

This study has been terminated.
(No Accrual)
Sponsor:
Information provided by:
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00205062
First received: September 13, 2005
Last updated: September 22, 2008
Last verified: September 2008
History of Changes
  Purpose

The main hypothesis is that PET-CT will be a valuable diagnostic tool in diagnosing and evaluating treatment for IBD.


Condition Intervention Phase
Inflammatory Bowel Diseases
 Procedure: PET-CT
 Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Pilot Study of the Role of PET-CT for Diagnosis and Assessment of Therapeutic Efficacy in Inflammatory Bowel Disease

Further study details as provided by University of Wisconsin, Madison:

Primary Outcome Measures:
  • Does this technique provide an accurate assessment of disease inflammation compared to standard clinical markers?

Secondary Outcome Measures:
  • Does this technique provide additional information for practitioners on extent of disease?

Study Start Date: October 2004
Study Completion Date: August 2008
Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patient with either Crohn's disease or ulcerative colitis whose disease is flaring

Exclusion Criteria:

  • Indeterminate diagnosis, pregnant, breastfeeding, or other contraindication to PET-CT
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00205062

Locations
United States, Wisconsin
University of Wisconsin
Madison, Wisconsin, United States, 53792
Sponsors and Collaborators
University of Wisconsin, Madison
Investigators
Principal Investigator: Randall Meisner, MD University of Wisconsin, Madison
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00205062     History of Changes
Other Study ID Numbers: M-2004-0251
Study First Received: September 13, 2005
Last Updated: September 22, 2008
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Inflammatory Bowel Diseases
Intestinal Diseases
Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases

ClinicalTrials.gov processed this record on May 16, 2013